Literature DB >> 8557857

Angiogenesis.

R A Swerlick1.   

Abstract

The formation of new blood vessels, angiogenesis, is a complex process which is central to normal development and homeostasis. However, uncontrolled angiogenesis plays a critical role in both inflammatory and neoplastic disorders. Our understanding of angiogenesis has expanded greatly over the past two decades due to the development of in vivo and in vitro models to study this important process. A variety of cytokines and growth factors have been shown to induce new blood vessel formation in vivo, and in vitro studies have been able to define whether agents have direct or indirect effects upon vascular endothelial cells. Our improved understanding of the mechanisms which regulate angiogenesis has now created important opportunities for the development of new therapies for the treatment of inflammatory and neoplastic skin disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557857     DOI: 10.1111/j.1346-8138.1995.tb03934.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma.

Authors:  Huilian Huang; Jing Li; Yongliang Lu; Lishan Min; Dongli Li; Licheng Dai
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 2.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

3.  Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Authors:  Andrew B Thompson; Douglas A Ross; Paul Berard; Jaszmin Figueroa-Bodine; Nancy Livada; Sara L Richer
Journal:  Allergy Rhinol (Providence)       Date:  2014-07-15

Review 4.  A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy.

Authors:  Chenhui Zhou; Yi Huang; Jingmi Wu; Yiting Wei; Xiaosheng Chen; Zhiqing Lin; Sheng Nie
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.